Can I invest in the Funds through my custodian bank?
Yes. Your custodian bank can set up an account for your benefit.
What service does Northern Trust provide to the Funds?
Northern Trust serves as Administrator and Depository for the Funds. Among its duties, Northern Trust acts as a transfer agent, responsible for the day-to-day administration of the Funds, including the processing of investor applications. Investors submitting an application to the Fund should do so directly with Northern Trust, via hard copy, to the address listed at the top of this page.
What is the Funds' dealing frequency?
The Fund has daily dealing, as defined by any day on which banks are open for business in London, New York, Dublin, and/or other places that the Directors may, with the consent of the Depository, determine and notify in advance to shareholders.
Once my account is established, how do I instruct a subsequent transaction?
Fax the completed Dealing Form to Northern Trust by the Dealing Deadline. Wire instructions are in the Account Application and Dealing Form.
What is the Dealing Deadline?
The Dealing Deadline is 3pm Irish time on each Dealing Day for receipt of subscription or redemption instructions. Instructions received after 3pm will not be processed until the following Dealing Day.
When and how must I deliver my subscription monies? When will proceeds be paid?
Subscription proceeds must be received by Northern Trust within two Business Days of the relevant Dealing Day by electronic transfer in the currency of the relevant share class in order to receive same-day processing. Please refer to the following chart for settlement periods by sub-fund:
Global Small Companies Equity
Emerging Markets Equity
Frontier Emerging Markets Equity
Redemption proceeds are paid electronically to an account in the name of the shareholder. We recommend that you confirm the repayment account details on file with Northern Trust prior to any redemption’s settlement.
How do I make changes to my account (e.g., contact information, authorized signers)?
Mail a letter of instruction signed by a current authorized individual with the updated information to the Funds, c/o the Shareholder Service Team listed at the top of this page. Be sure to reference the Fund name and your account number within the letter.
Are there any entry, exit, or repurchase charges?
There are no entry, exit, or repurchase charges. However, the Directors have discretion to impose fees such as an anti-dilution levy to protect shareholders in accordance with the terms of the Prospectus and the requirements of the Central Bank.
Does Harding Loevner Funds plc accept applications or trade instructions via e-mail?
No, the Funds do not accept e-mailed applications or trade instructions under any circumstances.
Please read the Prospectus carefully before investing.
You are using an old version of Internet Explorer. It may not display all features of this website. For the best experience, please update your browser.
NOTICE TO PERSONS IN AUSTRALIA AND NEW ZEALAND
The information on this website is issued by Trust Company (RE Services) Limited (ABN 45 003 278 831; AFSL 235150) as Responsible Entity of, and issuer of units in, the Harding Loevner Emerging Markets Equity Fund ARSN 604 215 296 (“Fund”), and approved by Harding Loevner LP (“Harding Loevner”), as the Investment Manager of the Fund. Harding Loevner is exempt from the requirement to hold an Australian financial services licence under the Corporations Act 2001 (Cth) in respect of the financial services it provides to wholesale clients, and is not licensed to provide financial services to retail clients, in Australia. Harding Loevner is regulated by the Securities and Exchange Commission of the United States of America under US laws, which differ from Australian laws.
The information on this website is provided for general information purposes only, and is not investment advice or research, nor is it to be construed as solicitation of an offer to buy or sell any financial product . Accordingly, reliance should not be placed on this website as the basis for making an investment or other decision. A product disclosure statement (PDS) issued by the Responsible Entity is available for the Fund. You should obtain and consider the PDS, and related materials, and consult your professional advisers before making any investment decision.
Statements of fact on this website have been obtained from and are based upon sources that the Responsible Entity and Harding Loevner believe to be reliable. Neither the Responsible Entity nor Harding Loevner gives any representation or warranty as to the reliability or accuracy of the information contained on this website. All opinions and estimates included on this website constitute judgements of the Responsible Entity and Harding Loevner as at the date of this website and are subject to change without notice.
I am an Australian wholesale client or a New Zealand eligible investor and agree to the terms above and wish to proceed.
Click "Continue" to visit the general pages of the adviser to the Funds, Harding Loevner LP.
Click "Continue" to visit the pages for Harding Loevner Funds, Inc., a family of mutual funds for US investors.
Harding Loevner is not responsible for the content, accuracy, or timeliness and does not make any warranties, expressed or implied, with regard to the information obtained from other websites. These links are provided for your convenience and for navigational purposes only. They should not be considered a recommendation to buy or sell any securities. It should not be assumed that investment in the securities identified has been or will be profitable.
By clicking on the "I Agree" button, you acknowledge that you have read and understood this disclaimer and wish to proceed.
Terms & Conditions
You are about to access the pages of Harding Loevner Funds plc, an Irish umbrella type open-ended investment company (the "Company"), which contains information about the Company and its sub-funds (each a "Fund"). These pages are for informational purposes only. It is not investment advice, nor is it intended to be relied on as a forecast or research and does not constitute an offer, recommendation or solicitation to buy or sell shares in any Fund. Access to and the information contained in these pages are restricted to persons who are residents of jurisdictions in which the distribution of the information herein is permitted. Please consult your professional advisers if you have questions about a particular investment or are unsure of the laws and regulations applicable to you.
Investment in any Fund may only be made in accordance with the terms of the relevant offering documents, and subject to the laws and regulations applicable in which the offering documents are distributed. Please further note that not all Funds are available for distribution in all or the same jurisdictions. No information regarding the offering of shares of the Funds is intended for, nor will offers or sales of such shares generally be made to, residents of the United States of America, its territories or possessions. In particular, neither the Funds nor any shares are or will be registered under the U.S. Securities Act of 1933, as amended, the U.S. Investment Company Act of 1940, as amended, or otherwise in the U.S. and may not, except in a transaction which does not violate U.S. securities laws, be directly or indirectly offered or sold in the U.S. or to any U.S. persons.
By clicking on the "I Agree" button below, you acknowledge that you have read and understood this disclaimer and wish to proceed to these pages.